(Q80376325)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17522506%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

title

A randomized, controlled trial of postoperative adjuvant interferon therapy after resection of hepatocellular carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17522506%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

main subject

hepatocellular carcinoma

1 reference

randomized controlled trial

inferred from title

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17522506%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

author name string

Chung Mau Lo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17522506%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Chi Leung Liu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17522506%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

See Ching Chan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17522506%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Chi Ming Lam

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17522506%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Ronnie T P Poon

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17522506%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Sheung Tat Fan

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17522506%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

John Wong

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17522506%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

language of work or name

English

0 references

publication date

1 June 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17522506%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17522506%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

volume

245

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17522506%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17522506%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

831-842

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17522506%20AND%20SRC:MED&resulttype=core&format=json

Adjuvant chemotherapy with epirubicin and carmofur after radical resection of hepatocellular carcinoma: a prospective randomized study

31 December 2019

cites work

1 reference

12 December 2020

Treatment of hepatocellular carcinoma

1 reference

12 December 2020

Inhibition of basic fibroblast growth factor expression, angiogenesis, and growth of human bladder carcinoma in mice by systemic interferon-alpha administration

1 reference

12 December 2020

Interferon decreases hepatocellular carcinogenesis in patients with cirrhosis caused by the hepatitis B virus: a pilot study

1 reference

12 December 2020

Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection

1 reference

12 December 2020

Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths

1 reference

12 December 2020

Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial

1 reference

12 December 2020

Postoperative adjuvant chemotherapy after curative resection of hepatocellular carcinoma: a randomized controlled trial

1 reference

12 December 2020

Long-term prognosis after resection of hepatocellular carcinoma associated with hepatitis B-related cirrhosis

1 reference

12 December 2020

High-dose and long-term therapy with interferon-alfa inhibits tumor growth and recurrence in nude mice bearing human hepatocellular carcinoma xenografts with high metastatic potential

1 reference

12 December 2020

Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor-A prospective randomized study of hepatitis C virus-related liver cancer

1 reference

12 December 2020

Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma

1 reference

12 December 2020

Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial

1 reference

12 December 2020

Effects of long-term postoperative interferon-alpha therapy on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. A randomized, controlled trial

1 reference

12 December 2020

Adjuvant chemotherapy after resection of hepatocellular carcinoma causes deterioration of long-term prognosis in cirrhotic patients: metaanalysis of three randomized controlled trials

1 reference

12 December 2020

Peginterferon-alpha-2a (40 kD): a review of its use in the management of chronic hepatitis C.

1 reference

12 December 2020

Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials

1 reference

12 December 2020

Effects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesis.

1 reference

12 December 2020

Peginterferon alpha-2a (40 kDa): an advance in the treatment of hepatitis B e antigen-positive chronic hepatitis B.

1 reference

12 December 2020

Mechanism of interferon alpha on inhibition of metastasis and angiogenesis of hepatocellular carcinoma after curative resection in nude mice.

1 reference

12 December 2020

Prospective randomized controlled study of interferon-alpha in preventing hepatocellular carcinoma recurrence after medical ablation therapy for primary tumors

1 reference

12 December 2020

Primary liver cancer. An Eastern Cooperative Oncology Group Trial

1 reference

12 December 2020

Clonal origin of human hepatoma determined by integration of hepatitis B virus DNA.

1 reference

12 December 2020

Clonal Origin of Recurrent Hepatocellular Carcinomas

1 reference

12 December 2020

Recombinant alpha 2 interferon is superior to doxorubicin for inoperable hepatocellular carcinoma: a prospective randomised trial

1 reference

12 December 2020

A controlled trial of interferon with or without prednisone priming for chronic hepatitis B

1 reference

12 December 2020

Long-term survival following treatment of hepatocellular carcinoma in Singapore: evaluation of Wellferon in the prophylaxis of high-risk pre-cancerous conditions

1 reference

12 December 2020

Recombinant interferon-alpha in inoperable hepatocellular carcinoma: a randomized controlled trial.

1 reference

12 December 2020

Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma

1 reference

12 December 2020

Multiple hepatocellular carcinomas at the early stage have different clonality

1 reference

12 December 2020

Hepatocellular carcinoma: surgical resection versus surgical resection combined with pre- and post-operative locoregional immunotherapy-chemotherapy. A prospective randomized study

1 reference

12 December 2020

Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B

1 reference

12 December 2020

Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group

1 reference

12 December 2020

10.1097/01.SLA.0000245829.00977.45

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17522506%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference